News Pharma Industry

An INR6,940 crore PLI scheme aims to secure Indian pharma’s supply chain. Here’s a progress report.

Representative Image.


Dependence on imported ingredients poses a huge risk for India’s pharma industry. In 2020, the government came up with a production-linked incentive scheme to encourage indigenous manufacturing of these critical products. With the highest-ever financing allocation for the pharmaceutical sector, there is no doubting the intent of the scheme. But two years on, is the initial promise intact?

K Anji Reddy, the late founder of Dr. Reddy’s Labs, was known for his cheeky humour. Decades ago, when a German trader wryly asked if he could match the quality of products from drugmaker Boots, the scientist-turned-entrepreneur in his inimitable style quipped, indeed, he just needed to add impurities to the product.Dr Reddy struck a fine balance of science and astute business sense. His desire to end the dominance of global giants was

  • SAVE

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

Source link

Leave a Comment